Galimedix Therapeutics presents new scientific data showing
GAL-201 specifically targets and binds to misfolded Aβ monomers, preventing their aggregation to toxic Aβ oligomers and protofibrilsAs a consequence, ...
Read moreGAL-201 specifically targets and binds to misfolded Aβ monomers, preventing their aggregation to toxic Aβ oligomers and protofibrilsAs a consequence, ...
Read moreRecent eMarketer Report Shows Growth in Influencer Marketing Spending is More Resilient than Traditional Ads on Social Media Thumzup’s Reg ...
Read moreOKX Leads the Way in Transparency and Trust with 14th Consecutive Proof of Reserves, Showing USD14.9 Billion in Primary Assets ...
Read moreBMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes ...
Read moreAddition of Affimed’s innate cell engager (ICE®) improves cytotoxicity of natural killer (NK) cells and CAR-NK cellsNK cells with ICE® ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.